Analyst Adam Jonas from Morgan Stanley maintained a Buy rating on American Axle (AXL – Research Report) and keeping the price target at ...

Closely following a Mediterranean-style diet — rich in fruits, vegetables, beans, olive oil and some fish and chicken — was associated with improved brain health in a study of Hispanic/Latino adults ...

Analyst Aaron Rakers of Wells Fargo maintained a Buy rating on Advanced Micro Devices (AMD – Research Report), retaining the price target of ...

According to a recent study, the tendency to experience positive affectivity contributed to people being physically active or even increasing their activity during the COVID-19 restrictions. In ...

According to a recent study published in BMC Public Health, the tendency to experience positive affectivity contributed to ...

SBI Cards and Payment Services Ltd.'s stock was upgraded to 'neutral' from 'sell' by UBS Global Research as positive factors suggest growth improvement. The brokerage raised the target price to Rs 800 ...

Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast ...

Most previous research in this area has looked at genetics passed down through generations, but here, the team was able to identify 15 different lifestyle and health factors that are associated with ...

Royal LePage president and CEO Phil Soper said in a statement that there are several factors "revitalizing Canada's real estate market and making home ownership more attainable", namely the Bank of ...

Job growth exceeds expectations, unemployment rate falls to 4.1% US central bank faces dilemma with strong job market, sticky inflation Some Fed officials suggesting rate cuts may be near an end ...

In 2024, there were several announcements about changes to business taxes that will take effect in 2025. We’ve gathered the key updates here, along with some helpful resources to make it easier to ...

PM-8002 is under clinical development by Biotheus and currently in Phase II for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer). According to GlobalData, Phase II ...